← Leaderboards
Lauren Balmert Bonner
Northwestern University
$4,445,085
Attributed
$9,527,340
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,527,340 · 3
By mechanism
U01$7,269,328 · 1
U24$1,911,512 · 1
U34$346,500 · 1
Top collaborators
- Parambir Singh Dulai4 shared
- Daniela P Ladner1 shared
- Abigail Smith1 shared
Most similar at Northwestern University
Same institution · by research overlap
- Daniela P Ladner$12,321,153
- Alan R Hauser$27,491,318
- Parambir Singh Dulai$5,769,384
- Sanjay Mehrotra$5,486,328
- Charles F Manski$1,768,834
Others in their field
Other Emerging Leaders on “Mortality”
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
- Barbara Halina Braffett · George Washington University$17,931,151
Research focus
MortalityMorbidity - Disease RateRandomizedDesignHemorrhageInflammationMedicalPreventCostUnited StatesDrug DevelopmentDoseBreathingAtmospheric PressureDisease OutcomeDouble-Blind MethodEffective TherapyCollectionBiological ProductsCellsColectomyChronicDigitalClinical Remission
Grant awards (5)
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial$2,464,155
U01 · FY2025 · DK
Liver Cirrhosis Network: Scientific and Data Coordination Center$1,911,512
U24 · FY2025 · DK
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial$2,365,589
U01 · FY2024 · DK
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial$2,439,584
U01 · FY2023 · DK
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Multi-Center, Randomized, Double-Blind, Sham Controlled Trial (HBOT-UC)$346,500
U34 · FY2021 · DK